iFR and FFR are equally safe to diagnose and treat heart disease according to largest-ever analysis of new real-world, long-term data
Kort samengevat
October 26, 2023 Safety of Philips’ iFR in the guidance of percutaneous coronary intervention (PCI) for heart disease demonstrated in late-breaking...
Verder lezen bij de bron
Bekijk het volledige nieuwsbericht rechtstreeks bij GlobeNewswire News Room.
Lees het volledige bericht ↗